These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 31152846)

  • 21. Crucial roles of RSK in cell motility by catalysing serine phosphorylation of EphA2.
    Zhou Y; Yamada N; Tanaka T; Hori T; Yokoyama S; Hayakawa Y; Yano S; Fukuoka J; Koizumi K; Saiki I; Sakurai H
    Nat Commun; 2015 Jul; 6():7679. PubMed ID: 26158630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel extracellular Hsp90 mediated co-receptor function for LRP1 regulates EphA2 dependent glioblastoma cell invasion.
    Gopal U; Bohonowych JE; Lema-Tome C; Liu A; Garrett-Mayer E; Wang B; Isaacs JS
    PLoS One; 2011 Mar; 6(3):e17649. PubMed ID: 21408136
    [TBL] [Abstract][Full Text] [Related]  

  • 23. mTORC2 Regulates Amino Acid Metabolism in Cancer by Phosphorylation of the Cystine-Glutamate Antiporter xCT.
    Gu Y; Albuquerque CP; Braas D; Zhang W; Villa GR; Bi J; Ikegami S; Masui K; Gini B; Yang H; Gahman TC; Shiau AK; Cloughesy TF; Christofk HR; Zhou H; Guan KL; Mischel PS
    Mol Cell; 2017 Jul; 67(1):128-138.e7. PubMed ID: 28648777
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Transcriptional control of cystine/glutamate transporter gene by amino acid deprivation.
    Sato H; Nomura S; Maebara K; Sato K; Tamba M; Bannai S
    Biochem Biophys Res Commun; 2004 Dec; 325(1):109-16. PubMed ID: 15522208
    [TBL] [Abstract][Full Text] [Related]  

  • 25. S897 phosphorylation of EphA2 is indispensable for EphA2-dependent nasopharyngeal carcinoma cell invasion, metastasis and stem properties.
    Li JY; Xiao T; Yi HM; Yi H; Feng J; Zhu JF; Huang W; Lu SS; Zhou YH; Li XH; Xiao ZQ
    Cancer Lett; 2019 Mar; 444():162-174. PubMed ID: 30583071
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of xCT and activity of system xc(-) are regulated by NRF2 in human breast cancer cells in response to oxidative stress.
    Habib E; Linher-Melville K; Lin HX; Singh G
    Redox Biol; 2015 Aug; 5():33-42. PubMed ID: 25827424
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Claudin-4 controls the receptor tyrosine kinase EphA2 pro-oncogenic switch through β-catenin.
    Shang X; Lin X; Howell SB
    Cell Commun Signal; 2014 Oct; 12():59. PubMed ID: 25344320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Glutamate suppresses osteoclastogenesis through the cystine/glutamate antiporter.
    Hinoi E; Takarada T; Uno K; Inoue M; Murafuji Y; Yoneda Y
    Am J Pathol; 2007 Apr; 170(4):1277-90. PubMed ID: 17392167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. EphA2 receptor is a key player in the metastatic onset of Ewing sarcoma.
    Garcia-Monclús S; López-Alemany R; Almacellas-Rabaiget O; Herrero-Martín D; Huertas-Martinez J; Lagares-Tena L; Alba-Pavón P; Hontecillas-Prieto L; Mora J; de Álava E; Rello-Varona S; Giangrande PH; Tirado OM
    Int J Cancer; 2018 Sep; 143(5):1188-1201. PubMed ID: 29582409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell adhesion and EGFR activation regulate EphA2 expression in cancer.
    Larsen AB; Stockhausen MT; Poulsen HS
    Cell Signal; 2010 Apr; 22(4):636-44. PubMed ID: 19948216
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Oncogenic PI3K promotes methionine dependency in breast cancer cells through the cystine-glutamate antiporter xCT.
    Lien EC; Ghisolfi L; Geck RC; Asara JM; Toker A
    Sci Signal; 2017 Dec; 10(510):. PubMed ID: 29259101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. EphA2 phosphorylation at Ser897 by the Cdk1/MEK/ERK/RSK pathway regulates M-phase progression via maintenance of cortical rigidity.
    Kaibori Y; Saito Y; Nakayama Y
    FASEB J; 2019 Apr; 33(4):5334-5349. PubMed ID: 30668924
    [TBL] [Abstract][Full Text] [Related]  

  • 33. EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with Akt.
    Miao H; Li DQ; Mukherjee A; Guo H; Petty A; Cutter J; Basilion JP; Sedor J; Wu J; Danielpour D; Sloan AE; Cohen ML; Wang B
    Cancer Cell; 2009 Jul; 16(1):9-20. PubMed ID: 19573808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Filamin A forms a complex with EphA2 and regulates EphA2 serine 897 phosphorylation and glioblastoma cell proliferation.
    Tamura Y; Nakamizo Y; Watanabe Y; Kimura I; Katoh H
    Biochem Biophys Res Commun; 2022 Mar; 597():64-70. PubMed ID: 35124461
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Functional interactions of the cystine/glutamate antiporter, CD44v and MUC1-C oncoprotein in triple-negative breast cancer cells.
    Hasegawa M; Takahashi H; Rajabi H; Alam M; Suzuki Y; Yin L; Tagde A; Maeda T; Hiraki M; Sukhatme VP; Kufe D
    Oncotarget; 2016 Mar; 7(11):11756-69. PubMed ID: 26930718
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cooperative action of glutamate transporters and cystine/glutamate antiporter system Xc- protects from oxidative glutamate toxicity.
    Lewerenz J; Klein M; Methner A
    J Neurochem; 2006 Aug; 98(3):916-25. PubMed ID: 16771835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RSK-Mediated Non-canonical Activation of EphA2 by Tamoxifen.
    Yonehara K; Zhou Y; Takahashi JI; Yokoyama S; Tomihara K; Noguchi M; Sakurai H
    Biol Pharm Bull; 2022; 45(2):162-168. PubMed ID: 35110502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Structure, function, and regulation of human cystine/glutamate transporter in retinal pigment epithelial cells.
    Bridges CC; Kekuda R; Wang H; Prasad PD; Mehta P; Huang W; Smith SB; Ganapathy V
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):47-54. PubMed ID: 11133847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cystine/glutamate antiporter xCT (SLC7A11) facilitates oncogenic RAS transformation by preserving intracellular redox balance.
    Lim JKM; Delaidelli A; Minaker SW; Zhang HF; Colovic M; Yang H; Negri GL; von Karstedt S; Lockwood WW; Schaffer P; Leprivier G; Sorensen PH
    Proc Natl Acad Sci U S A; 2019 May; 116(19):9433-9442. PubMed ID: 31000598
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In silico characterization of residues essential for substrate binding of human cystine transporter, xCT.
    Sharma M; Anirudh CR
    J Mol Model; 2019 Nov; 25(11):336. PubMed ID: 31705320
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.